secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001193125-23-060090
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.03, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics issues Series F Preferred Stock to Chairman with 50M votes per share on reverse split proposals
--------------------------------------------------------------------------------

- Issued one share of Series F Preferred Stock to Chairman Richard J. Hawkins for $1,000 cash.
- Preferred stock carries 50,000,000 votes per share, voting only on reverse stock split proposals in proportion to common stock votes.
- No conversion rights, no dividends, no liquidation preference; redeemable at board discretion or automatically upon stockholder approval of reverse split.
- Issuance exempt from registration under Rule 506 of Regulation D.
- Certificate of Designation filed with Delaware Secretary of State on March 3, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312523060090/0001193125-23-060090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312523060090/d449434d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-060090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer